• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number UNK776
Device Problem Occlusion Within Device (1423)
Patient Problems Atrial Fibrillation (1729); Cardiac Arrest (1762); Chest Pain (1776); Reocclusion (1985); Paralysis (1997); Thrombosis (2100); Ventricular Fibrillation (2130)
Event Date 02/14/2017
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) study.It was reported that stent thrombosis occurred.In (b)(6) 2016, patient was referred for cardiac catheterization and index procedure was performed.Target lesion was located in the distal right coronary artery (rca) with 99% stenosis and was 38mm long with a reference vessel diameter of 2.75mm.The lesion was treated with pre-dilatation and placement of a 3.00x38mm synergy¿ study stent.Following post-dilatation residual stenosis was 0%.The following day, the patient was discharged on dual antiplatelet therapy (aspirin and clopidogrel).In (b)(6) 2017, the patient presented to emergency department with recurrent symptoms of chest pain.Shortly after admission patient had cardiac arrest with ventricular fibrillation.Patient was successfully resuscitated however, was noted to be paralyzed.Subsequently, patient was intubated and transferred to critical care unit.Electrocardiogram revealed atrial fibrillation with st depressions.Subsequently, coronary angiography was performed and revealed, 40% stenosis in mid rca, 95% in-stent restenosis (isr) of the previously placed study stent in distal rca; 70% stenosis in distal rca.On the same day, the 95% isr of previously placed study stent in distal rca and 70% stenosis in distal rca was treated with pre-dilatation and placement of a 3x22mm non-bsc drug-eluting stent.Following post dilatation the residual stenosis was 0%.The event was classified as stent thrombosis.During the course of hospitalization, patient was found to have upper gastro intestinal bleeding and esophagogastroduodenoscopy findings revealed varix in the esophagus and 2 arterio-venous malformations in the stomach.Computerised tomography of the chest revealed bilateral rib fractures, right pleural effusion with heterogeneous attenuation that could be hemorrhagic and pulmonary contusions.Nine days from the onset of symptoms, patient was discharged on aspirin.
 
Manufacturer Narrative
Describe event or problem updated.(b)(4).
 
Event Description
It was further reported that no stent thrombosis occurred in the previously implanted study stent in distal right coronary artery.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2017, the patient presented to emergency department with sudden onset of chest pain and few days history of shortness of breath.The pain was sharp, midsternal and non-radiating in nature.The patient took one nitroglycerin at home following which improvement in pain was noted.On the same day, the patient was hospitalized for further investigation and treatment.Then, treatment with oral imdur was started.On the following day, event was considered resolved and the patient was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6385595
MDR Text Key69323098
Report Number2134265-2017-01840
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK776
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/16/2017
Initial Date FDA Received03/07/2017
Supplement Dates Manufacturer ReceivedNot provided
03/19/2018
Supplement Dates FDA Received04/14/2017
04/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
-
-